Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-06-06
1993-06-29
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, 530839, 530350, 435 692, A61K 3764, C07K 710
Patent
active
052234827
ABSTRACT:
DNA sequences encoding .beta.-amyloid-related proteins associated with Alzheimer's disease are disclosed. Also provided herein is a DNA sequence encoding a novel protease inhibitor. These sequences are used in producing or constructing recombinant .beta.-amyloid core protein, .beta.-amyloid-related proteins and recombinant or synthetic immunogenic peptides. Antibodies generated against the recombinant proteins or immunogenic peptides derived therefrom can be used for cerebral fluid or serum protein diagnosis of Alzheimer's disease.
REFERENCES:
patent: 4595674 (1986-06-01), Tschesche et al.
patent: 4666829 (1987-05-01), Glenner et al.
patent: 4912206 (1990-03-01), Goldgaber et al.
Holmes et al. "Characterization of Recombinant Human .alpha..sub.2 -Antiplasmin and of Mutants . . . ", Biochemistry vol. 26 pp. 5133-5140 (1987).
Tanzi et al. "Protease Inhibitor Domain Encoded by an Amyloid Protein . . . ", Nature v. 331, pp. 528-530 (Feb. 1988).
Carrell, Nature 331, 478-479 (Feb. 1988).
Abstract No. 90-285857/38.
Robakis et al., Proc Natl Acad Sci USA 84:4190-4194 (Jun. 1987).
Kang et al., Nature 325:733-736 (Feb. 19, 1987).
Goldgaber et al., Science 235:877-880 (Feb. 1987).
Neve et al., Biological Abstracts 83(6):1987.
Tanzi et al., Science 235:880-884 (Feb. 1987).
Masters et al., Chemical Abstracts 104(15) (Apr. 1986), pp. 506-507.
Masters et al., EMBO J 4(1):2757-2763 (1985).
Uzan et al., Biochem Biophys Res Comm 119:273-281 (Feb. 1984).
Masters et al., Proc Natl Acad Sci USA 82:4245-4249 (Jun. 1985).
Glenner and Wong, Biochem Biophys Res Comm 120(3):885-890 (May 1984).
Glenner et al., Biochem Biophys Res Comm 122:1131-1135 (Aug. 1984).
Glenner et al., "Amyloidosis", published by Plenum Press, Jun. 1986, pp. 693-701.
Roher et al., Proc Natl Acad Sci USA 82:2662-2666 (Apr. 1986).
Wong et al., Proc Natl Acad Sci USA 82:8729-8732 (Dec. 1985).
Ohtsuka et al., Biol Chem 269:2605-2608 (Mar. 1985).
Takahashi et al., Proc Natl Acad Sci USA 82:1931-1935 (Apr. 1985).
Robakis et al., Proc Natl Acad Sci USA 83:6377-6381 (1986).
Allsop et al., Neuroscience Letters 68:252-256 (1986).
Price et al., Drug Development Res 5:59-68 (1985).
Delabar et al., Science 235:1390-1392 (1987).
Barnes, Science 235:846-847 (1987).
Anderton, Nature 325:658-659 (1987).
Selkoe et al., Science 235:873-876 (1987).
Allsop et al., Brain Res 259:348-352 (1983).
Westermark and Cornwell, Amyloidosis, pp. 659-668 (1984).
Allsop et al., Amyloidosis, pp. 723-732 (1984).
St. George-Hyslop et al., Science 235:885-890 (1987).
Ponte et al., Nature, 331(6156):525-527 (1988).
Kitaguchi et al., Nature 331:530-532 (1988).
Shivers et al., EMBO J 7(5):1365-1370 (1988).
Dyrks et al., EMBO J 7(4):949-957 (1988).
Marks et al., J Biol Chem 261(16):7115-7118 (1986).
Tan and Kaiser, Biochem 16(8):1531-1541 (1977).
Gebhard et al., Protease Inhibitors, Barrett and Salvesen (eds.), 1986, Elsevier Science Publishers BV, pp. 375-388.
Fritz and Wunderer, Drug Res 33(1):479-494 (1983).
Cordell Barbara
Ponte Phyllis A.
Schilling, Jr. James W.
Bozicevic Karl
Hill Jr. Robert J.
Ossanna Nina
Scios Nova Inc.
LandOfFree
Recombinant Alzheimer's protease inhibitory amyloid protein and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant Alzheimer's protease inhibitory amyloid protein and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant Alzheimer's protease inhibitory amyloid protein and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755361